MONTE ROSA THERAPEUTICS INC (GLUE) Stock Cash Flow
NASDAQ:GLUE - Nasdaq - US61225M1027 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 6.15M | -72.70M | -135.35M | -108.50M | -73.96M | |||
| Depreciation Amortization | 8.27M | 8.12M | 6.22M | 3.75M | 2.13M | |||
| Change In Working Capital | 5.66M | 91.40M | 72.47M | -2.13M | 6.29M | |||
| Other non cash items | 14.58M | 15.18M | 12.86M | 14.42M | 6.18M | |||
| OPERATING CASH FLOW | 34.67M | 42.00M | -43.80M | -92.47M | -59.36M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.19M | -3.99M | -19.04M | -12.91M | -9.73M | |||
| Other Investing Activity | -150.34M | -40.46M | 107.84M | -206.31M | 80.00K | |||
| INVESTING CASH FLOW | -154.53M | -44.45M | 88.80M | -219.22M | -9.65M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 98.66M | 98.89M | 27.49M | 20.83M | 380.90M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -360.00K | -3.34M | |||
| FINANCING CASH FLOW | 98.66M | 98.89M | 27.49M | 20.47M | 377.56M | |||
| CHANGE IN CASH | -21.20M | 96.44M | 72.49M | -291.22M | 308.55M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 34.67M | 42.00M | -43.80M | -92.47M | -59.36M | |||
| Capital Expenditure | -4.19M | -3.99M | -19.04M | -12.91M | -9.73M | |||
| FREE CASH FLOW | 30.48M | 38.01M | -62.84M | -105.38M | -69.09M | |||
All data in USD